These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8386307)

  • 1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
    Nantel F; Bonin H; Emorine LJ; Zilberfarb V; Strosberg AD; Bouvier M; Marullo S
    Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.
    Liggett SB; Freedman NJ; Schwinn DA; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3665-9. PubMed ID: 8386380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of beta-agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells.
    Penn RB; Kelsen SG; Benovic JL
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):496-505. PubMed ID: 7917318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
    Rousseau G; Nantel F; Bouvier M
    Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
    Campbell PT; Hnatowich M; O'Dowd BF; Caron MG; Lefkowitz RJ; Hausdorff WP
    Mol Pharmacol; 1991 Feb; 39(2):192-8. PubMed ID: 1847493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
    Bouvier M; Hnatowich M; Collins S; Kobilka BK; Deblasi A; Lefkowitz RJ; Caron MG
    Mol Pharmacol; 1988 Feb; 33(2):133-9. PubMed ID: 2828911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites.
    Liggett SB; Bouvier M; Hausdorff WP; O'Dowd B; Caron MG; Lefkowitz RJ
    Mol Pharmacol; 1989 Oct; 36(4):641-6. PubMed ID: 2554115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
    Suzuki T; Nguyen CT; Nantel F; Bonin H; Valiquette M; Frielle T; Bouvier M
    Mol Pharmacol; 1992 Mar; 41(3):542-8. PubMed ID: 1347641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase.
    Clark RB; Friedman J; Dixon RA; Strader CD
    Mol Pharmacol; 1989 Sep; 36(3):343-8. PubMed ID: 2550773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
    Zhu SJ; Toews ML
    Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
    Proll MA; Clark RB; Butcher RW
    Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
    Guan XM; Amend A; Strader CD
    Mol Pharmacol; 1995 Sep; 48(3):492-8. PubMed ID: 7565630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous desensitization of the beta-adrenergic receptor. Functional integrity of the desensitized receptor from mammalian lung.
    Strasser RH; Cerione RA; Codina J; Caron MG; Lefkowitz RJ
    Mol Pharmacol; 1985 Sep; 28(3):237-45. PubMed ID: 2993846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine-induced desensitization in turkey erythrocytes: cAMP mediated impairment of high affinity agonist binding without alteration in receptor number.
    Stadel JM; De Lean A; Mullikin-Kilpatrick D; Sawyer DD; Lefkowitz RJ
    J Cyclic Nucleotide Res; 1981; 7(1):37-47. PubMed ID: 6265513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line.
    Scarpace PJ; Baresi LA; Sanford DA; Abrass IB
    Mol Pharmacol; 1985 Dec; 28(6):495-501. PubMed ID: 2867463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.